Multiply high-level-aminoglycoside-resistant enterococci isolated from XXXX in a university hospital.

@entity1 @entity801 @entity7913 @entity693 @entity3639 @entity281 @entity884
Enterococci isolated from different body sites were tested for high-level @entity801 resistance. A total of 259 enterococcal isolates were screened for resistance (MIC, greater than 2,000 micrograms/ml) by a broth-tube method. Thirty-nine (15.1%) were found to exhibit resistance and were confirmed by agar screening (1,000 micrograms/ml) and agar dilution MIC determinations. The majority of isolates also showed high-level resistance to @entity7913 and @entity3639 . The remaining isolates showed high-level resistance to @entity801 and @entity7913 but not @entity3639 . Synergy testing of several isolates confirmed the correlation between lack of synergy and high-level resistance. A retrospective clinical review was performed. Most @entity1 had a source of @entity281 (79%). Serious infections such as @entity884 or @entity693 were not observed during the course of this study. Retrospective clinical data suggest that in cases not involving @entity884 or @entity693 , neither @entity281 refractory to therapy nor relapse of @entity281 is a common sequela of @entity281 with @entity801 -resistant enterococci in hospitalized @entity1 .
